• Regeneron Pharmaceuticals average pre-tax profit margin for 2024 was 33.61%, a 4.52% increase from 2023.
• Regeneron Pharmaceuticals average pre-tax profit margin for 2023 was 35.2%, a 23.43% decline from 2022.
• Regeneron Pharmaceuticals average pre-tax profit margin for 2022 was 45.97%, a 17.76% decline from 2021.

Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.